The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections

The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) began development of a broad-spectrum antiviral countermeasure against deliberate use of high-consequence viral hemorrhagic fevers (VHFs) in 2016. The effort featured comprehensive preclinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Hickman, Mark R., Saunders, David L., Bigger, Catherine A., Kane, Christopher D., Iversen, Patrick L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903284/
https://www.ncbi.nlm.nih.gov/pubmed/35259154
http://dx.doi.org/10.1371/journal.pntd.0010220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903284/
https://www.ncbi.nlm.nih.gov/pubmed/35259154
http://dx.doi.org/10.1371/journal.pntd.0010220

Ejemplares similares